Finally, the PI3K/AKT/FOXO signaling pathway was identified as a potential target mechanism that reduced the incidence of BRCA in SLE patients with both MME-related proteins and miRNAs. This evidence concerns the gene AKT1 and systemic lupus erythematosus.